Rhumbline Advisers Grows Stake in Chemours Company (The) (CC)

Rhumbline Advisers grew its holdings in Chemours Company (The) (NYSE:CC) by 8.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 399,843 shares of the specialty chemicals company’s stock after purchasing an additional 30,165 shares during the quarter. Rhumbline Advisers owned approximately 0.22% of Chemours Company (The) worth $20,236,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CC. Acrospire Investment Management LLC boosted its position in Chemours Company (The) by 3.4% during the second quarter. Acrospire Investment Management LLC now owns 3,076 shares of the specialty chemicals company’s stock worth $117,000 after acquiring an additional 100 shares during the last quarter. Cypress Capital Management LLC boosted its position in Chemours Company (The) by 0.5% during the second quarter. Cypress Capital Management LLC now owns 31,393 shares of the specialty chemicals company’s stock worth $1,190,000 after acquiring an additional 155 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Chemours Company (The) by 0.6% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,921 shares of the specialty chemicals company’s stock worth $1,021,000 after acquiring an additional 167 shares during the last quarter. Commerce Bank boosted its position in Chemours Company (The) by 3.0% during the second quarter. Commerce Bank now owns 7,158 shares of the specialty chemicals company’s stock worth $272,000 after acquiring an additional 206 shares during the last quarter. Finally, World Asset Management Inc boosted its position in Chemours Company (The) by 4.0% during the second quarter. World Asset Management Inc now owns 15,652 shares of the specialty chemicals company’s stock worth $594,000 after acquiring an additional 597 shares during the last quarter. Institutional investors and hedge funds own 74.04% of the company’s stock.

A number of equities analysts have weighed in on CC shares. Zacks Investment Research downgraded shares of Chemours Company (The) from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 18th. UBS AG increased their price target on shares of Chemours Company (The) from $50.00 to $59.00 and gave the stock a “neutral” rating in a research note on Friday, November 3rd. Barclays PLC increased their price target on shares of Chemours Company (The) from $55.00 to $58.00 and gave the stock an “overweight” rating in a research note on Monday, November 6th. Jefferies Group LLC increased their price target on shares of Chemours Company (The) to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Finally, BidaskClub raised shares of Chemours Company (The) from a “hold” rating to a “buy” rating in a research note on Thursday, August 24th. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $53.89.

ILLEGAL ACTIVITY NOTICE: “Rhumbline Advisers Grows Stake in Chemours Company (The) (CC)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://sportsperspectives.com/2017/11/21/rhumbline-advisers-grows-stake-in-chemours-company-the-cc.html.

In other news, SVP David C. Shelton sold 13,337 shares of the firm’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $48.48, for a total value of $646,577.76. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider E Bryan Snell sold 11,878 shares of the firm’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $53.25, for a total transaction of $632,503.50. Following the completion of the transaction, the insider now directly owns 63,063 shares in the company, valued at approximately $3,358,104.75. The disclosure for this sale can be found here. In the last three months, insiders sold 76,520 shares of company stock worth $4,008,293. Insiders own 1.14% of the company’s stock.

Chemours Company (NYSE:CC) opened at $51.93 on Tuesday. Chemours Company has a one year low of $20.76 and a one year high of $58.08. The company has a quick ratio of 1.63, a current ratio of 2.19 and a debt-to-equity ratio of 5.07. The company has a market cap of $9,500.00 and a price-to-earnings ratio of 18.62.

Chemours Company (The) (NYSE:CC) last issued its earnings results on Thursday, November 2nd. The specialty chemicals company reported $1.12 EPS for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.11. Chemours Company (The) had a net margin of 4.86% and a return on equity of 116.80%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the firm posted $0.61 EPS. The business’s revenue for the quarter was up 13.3% compared to the same quarter last year. sell-side analysts forecast that Chemours Company will post 3.73 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Monday, November 20th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date is Friday, November 17th. Chemours Company (The)’s dividend payout ratio is presently 8.28%.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply